(A-C) Human CB-derived CD34 + cells were transduced with an LV expressing a shRNA against CypA or a nonsilencing control at an MOI of 100 and knock-down (KD) of CypA was verified by Western Blot (A) and by mRNA expression (B (P-R) Late-RT and 2LTR circle replication intermediates were measured in CB-CD34 + cells transduced with an LV MOI 100 at 6 or 24 hours post-transduction, respectively. LateRT and 2LTR products were expressed as copies/cell in P and Q, as the ratio between 2LTR/lateRT copies in R (mean ± SEM, n≥3). (C) THP-1 deleted for IFITM3 were re-challenged with a reporter LV at MOI 1 +/-8µM CsH. IFITM3 protein levels were evaluated at time of transduction (mean ± SEM, n=10, Mann Whitney test vs. each control without hIFNα, ns=not significant, **p≤0.01, ***p≤0.001). THP-1 cells over-expressing IFITM3 were transduced (D) with P90A or N74D capsid mutants (mean ± SEM, n=4, Mann Whitney test vs. each control Luc, *p≤0.05) or (E) an integrase-defective lentiviral vector (IDLV) (mean ± SEM, n=6, Mann Whitney test vs. Luc, **p=0.0022). 
